The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Discovery and development of safe-in-man broad-spectrum antiviral agents
Open accessAbstract
Viral diseases are one of the leading causes of morbidity and mortality in the world. Virus-specific vaccines and antiviral drugs are the most powerful tools to combat viral diseases. However, broad-spectrum antiviral agents (BSAAs, i.e. compounds targeting viruses belonging to two or more viral families) could provide additional protection of the general population from emerging and re-emerging viral diseases, reinforcing the arsenal of available antiviral options. Here, we review discovery and development of BSAAs and summarize the information on 120 safe-in-man agents in a freely accessible database (https://drugvirus.info/). Future and ongoing pre-clinical and clinical studies will increase the number of BSAAs, expand the spectrum of their indications, and identify drug combinations for treatment of emerging and re-emerging viral infections as well as co-infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Drug repurposing: progress, challenges and recommendations
Pushpakom, S., Iorio, F., Eyers, P. A., Escott, K. J., Hopper, S., Wells, A., Doig, A., Guilliams, T., Latimer, J., McNamee, C., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.168 · Cited by 4,718
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
Hui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.009 · Cited by 3,809
PubChem 2019 update: improved access to chemical data
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1033 · Cited by 3,249
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Sheahan, T. P., Sims, A. C., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrc, K., Feng, J. Y., Trantcheva, I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3653 · Cited by 1,571
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Analysis of drug combinations: current methodological landscape
Foucquier, J., & Guedj, M. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.149 · Cited by 1,115 · cited 1×
“By contrast to individual drugs, combinations of 2–3 BSAAs could be used to target an even broader range of viruses (Foucquier and Guedj, 2015; Zheng et al., 2018).”
BackgroundBroad-Spectrum Antiviral Activity of Virazole: 1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
Sidwell, R. W., Huffman, J. H., Khare, L., Allen, B., Witkowski, R., & Robins, K. (1972) · Science · doi:10.1126/science.177.4050.705 · Cited by 985
Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2951-z · Cited by 713
Are animal models predictive for humans?
Shanks, N., Greek, R., & Greek, J. (2009) · Philosophy, Ethics, and Humanities in Medicine · doi:10.1186/1747-5341-4-2 · Cited by 677
Xu, M., Lee, E. M., Wen, Z., Cheng, Y., Huang, W.-K., Qian, X., TCW, J., Kouznetsova, J., Ogden, S. C., Hammack, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4184 · Cited by 641
S., P. (2011) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.81895 · Cited by 541
Sarzotti-Kelsoe, M., Bailer, R. T., Turk, E., Lin, C.-L., Bilska, M., Greene, K. M., Gao, H., Todd, C. A., Ozaki, D. A., Seaman, M. S., et al. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2013.11.022 · Cited by 532
Eurosurveillance editorial team (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.5.200131e · Cited by 504
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
Barrows, N. J., Campos, R. K., Powell, S. T., Prasanth, K. R., Schott-Lerner, G., Soto-Acosta, R., Galarza-Muñoz, G., McGrath, E. L., Urrabaz-Garza, R., Gao, J., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.004 · Cited by 497
Animal Models are Essential to Biological Research: Issues and Perspectives
Barré-Sinoussi, F., & Montagutelli, X. (2015) · Future Science OA · doi:10.4155/fso.15.63 · Cited by 457
Methods in virus diagnostics: From ELISA to next generation sequencing
Boonham, N., Kreuze, J., Winter, S., van der Vlugt, R., Bergervoet, J., Tomlinson, J., & Mumford, R. (2014) · Virus Research · doi:10.1016/j.virusres.2013.12.007 · Cited by 448
Common Genetic Variants Modulate Pathogen-Sensing Responses in Human Dendritic Cells
Lee, M. N., Ye, C., Villani, A.-C., Raj, T., Li, W., Eisenhaure, T. M., Imboywa, S. H., Chipendo, P. I., Ran, F. A., Slowikowski, K., et al. (2014) · Science · doi:10.1126/science.1246980 · Cited by 442
Key Concepts of Clinical Trials: A Narrative Review
Umscheid, C. A., Margolis, D. J., & Grossman, C. E. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.09.2475 · Cited by 410
Watanabe, M., Buth, J. E., Vishlaghi, N., de la Torre-Ubieta, L., Taxidis, J., Khakh, B. S., Coppola, G., Pearson, C. A., Yamauchi, K., Gong, D., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.047 · Cited by 401
Li, C., Deng, Y.-Q., Wang, S., Ma, F., Aliyari, R., Huang, X.-Y., Zhang, N.-N., Watanabe, M., Dong, H.-L., Liu, P., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.012 · Cited by 344
High-throughput screening and identification of potent broad-spectrum inhibitors of coronaviruses.
Shen, L., Niu, J., Wang, C., Huang, B., Wang, W., Zhu, N., Deng, Y., Wang, H., Ye, F., Cen, S., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00023-19 · Cited by 319
Zhou, N., Pan, T., Zhang, J., Li, Q., Zhang, X., Bai, C., Huang, F., Peng, T., Zhang, J., Liu, C., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716100 · Cited by 286
Animal Models of Zika Virus Infection, Pathogenesis, and Immunity
Morrison, T. E., & Diamond, M. S. (2017) · Journal of Virology · doi:10.1128/jvi.00009-17 · Cited by 275 · cited 1×
“These include immunocompetent and genetically or chemically immunocompromised mice, guinea pigs, hamsters, ferrets, pigs, macaques and other animals (Figure 2B) (Alves et al., 2018; Haese et al., 2016; Louz et al., 2013; Morrison and Diamond, 2017; Taylor, 2017; Thangavel and Bouvier, 2014).”
Zhang, Y.-H., Zhao, Y., Li, N., Peng, Y.-C., Giannoulatou, E., Jin, R.-H., Yan, H.-P., Wu, H., Liu, J.-H., Liu, N., et al. (2013) · Nature Communications · doi:10.1038/ncomms2433 · Cited by 265
Zhou, T., Tan, L., Cederquist, G. Y., Fan, Y., Hartley, B. J., Mukherjee, S., Tomishima, M., Brennand, K. J., Zhang, Q., Schwartz, R. E., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.06.017 · Cited by 263
Young, D. D., Connelly, C. M., Grohmann, C., & Deiters, A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910275u · Cited by 260
The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication
Sacramento, C. Q., de Melo, G. R., de Freitas, C. S., Rocha, N., Hoelz, L. V. B., Miranda, M., Fintelman-Rodrigues, N., Marttorelli, A., Ferreira, A. C., Barbosa-Lima, G., et al. (2017) · Scientific Reports · doi:10.1038/srep40920 · Cited by 247
Drug repurposing screens and synergistic drug‐combinations for infectious diseases
Zheng, W., Sun, W., & Simeonov, A. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13895 · Cited by 247
Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide
Wu, C.-J., Jan, J.-T., Chen, C.-M., Hsieh, H.-P., Hwang, D.-R., Liu, H.-W., Liu, C.-Y., Huang, H.-W., Chen, S.-C., Hong, C.-F., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2693-2696.2004 · Cited by 240
Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
Jurgeit, A., McDowell, R., Moese, S., Meldrum, E., Schwendener, R., & Greber, U. F. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002976 · Cited by 231
Animal models of respiratory syncytial virus infection
Taylor, G. (2017) · Vaccine · doi:10.1016/j.vaccine.2016.11.054 · Cited by 202
Modeling rotavirus infection and antiviral therapy using primary intestinal organoids
Yin, Y., Bijvelds, M., Dang, W., Xu, L., van der Eijk, A. A., Knipping, K., Tuysuz, N., Dekkers, J. F., Wang, Y., de Jonge, J., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.09.010 · Cited by 199
Emerging virus diseases: can we ever expect the unexpected?
Howard, C. R., & Fletcher, N. F. (2012) · Emerging Microbes & Infections · doi:10.1038/emi.2012.47 · Cited by 194
A CRISPR toolbox to study virus–host interactions
Puschnik, A. S., Majzoub, K., Ooi, Y. S., & Carette, J. E. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.29 · Cited by 191
Animal models for influenza virus pathogenesis, transmission, and immunology
Thangavel, R. R., & Bouvier, N. M. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.03.023 · Cited by 190
Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification
Deans, R. M., Morgens, D. W., Ökesli, A., Pillay, S., Horlbeck, M. A., Kampmann, M., Gilbert, L. A., Li, A., Mateo, R., Smith, M., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2050 · Cited by 182
Pickett, B. E., Greer, D. S., Zhang, Y., Stewart, L., Zhou, L., Sun, G., Gu, Z., Kumar, S., Zaremba, S., Larsen, C. N., et al. (2012) · Viruses · doi:10.3390/v4113209 · Cited by 178
Yang, S., Xu, M., Lee, E. M., Gorshkov, K., Shiryaev, S. A., He, S., Sun, W., Cheng, Y.-S., Hu, X., Tharappel, A. M., et al. (2018) · Cell Discovery · doi:10.1038/s41421-018-0034-1 · Cited by 177
Screening Bioactives Reveals Nanchangmycin as a Broad Spectrum Antiviral Active against Zika Virus
Rausch, K., Hackett, B. A., Weinbren, N. L., Reeder, S. M., Sadovsky, Y., Hunter, C. A., Schultz, D. C., Coyne, C. B., & Cherry, S. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.068 · Cited by 172
Xu, Y., Qiu, Y., Zhang, B., Chen, G., Chen, Q., Wang, M., Mo, F., Xu, J., Wu, J., Zhang, R., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0152-9 · Cited by 168
Habjan, M., Penski, N., Spiegel, M., & Weber, F. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/002097-0 · Cited by 161
Ursu, O., Holmes, J., Bologa, C., Yang, J. J., Mathias, S. L., Stathias, V., Nguyễn, Ð.-T., Schürer, S. C., & Oprea, T. I. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky963 · Cited by 150
Importance of Drug Pharmacokinetics at the Site of Action
Rizk, M. L., Zou, L., Savić, R. M., & Dooley, K. E. (2017) · Clinical and Translational Science · doi:10.1111/cts.12448 · Cited by 148
Xia, Y., Carpentier, A., Cheng, X., Block, P. D., Zhao, Y., Zhang, Z., Protzer, U., & Liang, T. J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.009 · Cited by 146
Guide to Research Techniques in Neuroscience
(2015) · Elsevier eBooks · doi:10.1016/c2013-0-06868-5 · Cited by 143
Animal Models of Respiratory Syncytial Virus Infection
Byrd, L. G., & Prince, G. A. (1997) · Clinical Infectious Diseases · doi:10.1086/516152 · Cited by 143
Quimque, M. T. J., Notarte, K. I., Fernandez, R. A. T., Mendoza, M. A. O., Liman, R. A. D., Lim, J. A. K., Pilapil, L. A. E., Ong, J. K. H., Pastrana, A. M., Khan, A., et al. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1776639 · Cited by 133
Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses
Hulseberg, C. E., Fénéant, L., Wijs, K. S.-D., Kessler, N., Nelson, E. A., Shoemaker, C. J., Schmaljohn, C. S., Polyak, S. J., & White, J. M. (2019) · Journal of Virology · doi:10.1128/jvi.02185-18 · Cited by 128
Emerging Viral Diseases: Confronting Threats with New Technologies
Marston, H. D., Folkers, G. K., Morens, D. M., & Fauci, A. S. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009872 · Cited by 126
Pizzorno, A., Padey, B., Terrier, O., & Rosa-Calatrava, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00531 · Cited by 122 · cited 2×
“…opportunities, including a substantially higher probability of success to market as compared with developing new virus-specific drugs and vaccines, and a significantly reduced cost and timeline to clinical availability (Ianevski et al., 2019; Pizzorno et al., 2019; Zheng et al., 2018).”
Wang, Y., Lu, J., Lin, C.-C., Chin, Y., Wu, T., Lin, L., Lai, Z.-Z., Kuo, S.-C., & Ho, Y. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.10.003 · Cited by 113
Beyond Members of the Flaviviridae Family, Sofosbuvir Also Inhibits Chikungunya Virus Replication
Ferreira, A. C., Reis, P. A., de Freitas, C. S., Sacramento, C. Q., Hoelz, L. V. B., Bastos, M. M., Mattos, M., da Rocha, N. C., de Azevedo-Quintanilha, I. G., Pedrosa, C. D. S. G., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01389-18 · Cited by 112
Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity
Boonyasuppayakorn, S., Reichert, E. D., Manzano, M., Nagarajan, K., & Padmanabhan, R. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.03.014 · Cited by 111
Gopinath, S., Kim, M. V., Rakib, T., Wong, P., Zandt, M. C. V., Barry, N. A., Kaisho, T., Goodman, A. L., & Iwasaki, A. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0138-2 · Cited by 105
Pathogen detection in the CRISPR–Cas era
Sashital, D. G. (2018) · Genome Medicine · doi:10.1186/s13073-018-0543-4 · Cited by 101
Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine
Andersen, P. I., Krpina, K., Ianevski, A., Shtaida, N., Jo, E., Yang, J., Koit, S., Tenson, T., Hukkanen, V., Anthonsen, M. W., et al. (2019) · Viruses · doi:10.3390/v11100964 · Cited by 99
Self-citationUtt, A., Quirin, T., Saul, S., Hellström, K., Ahola, T., & Merits, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151616 · Cited by 97
Kuivanen, S. H., Bespalov, M. M., Nandania, J., Ianevski, A., Velagapudi, V., Brabander, J. K. D., Kainov, D. E., & Vapalahti, O. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2016.12.022 · Cited by 90
Self-citationMale germ cells support long-term propagation of Zika virus
Robinson, C. L., Chong, A. C. N., Ashbrook, A. W., Jeng, G., Jin, J., Chen, H., Tang, E. I., Martin, L. A., Kim, R. S., Kenyon, R., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04444-w · Cited by 89
Fifty Years in Search of Selective Antiviral Drugs
Clercq, E. D. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00175 · Cited by 88
Improving therapy of severe infections through drug repurposing of synergistic combinations
Cheng, Y., Williamson, P. R., & Zheng, W. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.07.006 · Cited by 86
Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection
Denisova, O. V., Kakkola, L., Feng, L., Stenman, J. J. E., Nagaraj, A. S., Lampe, J. W., Yadav, B., Aittokallio, T. A., Kaukinen, P., Ahola, T., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.392142 · Cited by 85
Self-citationKao, J.-C., HuangFu, W., Tsai, T.-T., Ho, M.-R., Jhan, M.-K., Shen, T., Tseng, P., Wang, Y.-T., & Lin, C. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006715 · Cited by 81
Thiazolides as Novel Antiviral Agents. 1. Inhibition of Hepatitis B Virus Replication
Stachulski, A. V., Pidathala, C., Row, E. C., Sharma, R., Berry, N. G., Iqbal, M., Bentley, J., Allman, S. A., Edwards, G., Helm, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200153p · Cited by 79
Using the Ferret as an Animal Model for Investigating Influenza Antiviral Effectiveness
Oh, D. Y., & Hurt, A. C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00080 · Cited by 78
Common Nodes of Virus–Host Interaction Revealed Through an Integrated Network Analysis
Bösl, K., Ianevski, A., Than, T. T., Andersen, P. I., Kuivanen, S. H., Teppor, M., Žusinaite, E., Dumpis, U., Vitkauskienė, A., Cox, R. J., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02186 · Cited by 78
Self-citationValadão, A. L. C., Abreu, C. M., Dias, J. Z. D. C., Arantes, P. R., Verli, H., Tanuri, A., & Aguiar, R. S. (2015) · Molecules · doi:10.3390/molecules200611474 · Cited by 77
The applications of CRISPR /Cas system in molecular detection
Zhou, L., Peng, R., Zhang, R., & Li, J. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13925 · Cited by 76
König, A., Yang, J., Jo, E., Park, K.-H. P., Kim, H., Than, T. T., Song, X., Qi, X., Dai, X., Park, S., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.010 · Cited by 76
Novel activities of safe-in-human broad-spectrum antiviral agents
Ianevski, A., Žusinaite, E., Kuivanen, S. H., Strand, M., Lysvand, H., Teppor, M., Kakkola, L., Paavilainen, H., Laajala, M., Kallio‐Kokko, H., et al. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.04.016 · Cited by 71
Self-citationMüller, K. H., Kainov, D. E., Bakkouri, K. E., Saelens, X., Brabander, J. K. D., Kittel, C., Samm, E., & Muller, C. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01346.x · Cited by 70
Self-citationIdentification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry
Mazzon, M., Ortega‐Prieto, A. M., Imrie, D., Luft, C., Hess, L., Czieso, S., Grove, J., Skelton, J. K., Farleigh, L. E., Bugert, J. J., et al. (2019) · Viruses · doi:10.3390/v11020176 · Cited by 69
The future of antivirals: broad-spectrum inhibitors
Debing, Y., Neyts, J. H., & Delang, L. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000212 · Cited by 68
Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease
Montoya, M. C., & Krysan, D. J. (2018) · mBio · doi:10.1128/mbio.02272-18 · Cited by 68
Efficacy and Mechanism of Action of Low Dose Emetine against Human Cytomegalovirus
Mukhopadhyay, R., Roy, S., Venkatadri, R., Su, Y., Ye, W., Barnaeva, E. S., Griner, L. A. M., Southall, N. T., Hu, X., Wang, A. Q., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005717 · Cited by 66
Söderholm, S., Kainov, D. E., Öhman, T., Denisova, O. V., Schepens, B., Kulesskiy, E., Imanishi, S. Y., Corthals, G. L., Hintsanen, P., Aittokallio, T. A., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.057984 · Cited by 65
Self-citationInsertion of a GFP Reporter Gene in Influenza Virus
Perez, J. T., García‐Sastre, A., & Manicassamy, B. (2013) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc15g04s29 · Cited by 62
Fang, J., Sun, L., Peng, G., Xu, J., Zhou, R., Cao, S., Chen, H., & Song, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078425 · Cited by 56
6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling
Yin, Y., Chen, S., Hakim, M. S., Wang, W., Xu, L., Dang, W., Qu, C., Verhaar, A. P., Su, J., Fuhler, G. M., et al. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.06.011 · Cited by 56
Yin, Y., Wang, Y., Dang, W., Xu, L., Su, J., Zhou, X., Wang, W., Felczak, K., van der Laan, L. J. W., Pankiewicz, K. W., et al. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.07.017 · Cited by 55
Kakkola, L., Denisova, O. V., Tynell, J., Viiliäinen, J., Ysenbaert, T., Matos, R. C., Nagaraj, A., Öhman, T., Kuivanen, S., Paavilainen, H., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.267 · Cited by 54
Self-citationLineage-Specific Real-Time RT-PCR for Yellow Fever Virus Outbreak Surveillance, Brazil
Fischer, C., Torres, M. C. V., Patel, P., Moreira‐Soto, A., Gould, E. A., Charrel, R. N., de Lamballerie, X. N., Nogueira, R. M. R., de Sequeira, P. C., Rodrigues, C. D. S., et al. (2017) · Emerging infectious diseases · doi:10.3201/eid2311.171131 · Cited by 51
Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs
Postnikova, E. N., Cong, Y., DeWald, L. E., Dyall, J., Yú, S., Hart, B. J., Zhou, H., Gross, R., Logue, J., Caì, Y., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194880 · Cited by 51
MacGibeny, M. A., Koyuncu, O. Ö., Wirblich, C., Schnell, M. J., & Enquist, L. W. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007188 · Cited by 51
Babadaei, M. M. N., Hasan, A., Vahdani, Y., Bloukh, S. H., Sharifi, M., Kachooei, E., Haghighat, S., & Falahati, M. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1767210 · Cited by 50
The fall and rise of in vivo pharmacology
Alabaster, V. A. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01882-4 · Cited by 49
Lanko, K., Eggermont, K., Patel, A. M., Kaptein, S. J. F., Delang, L., Verfaillie, C. M., & Neyts, J. H. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.07.010 · Cited by 48
Laamiri, N., Aouini, R., Marnissi, B., Ghram, A., & Hmila, I. (2017) · Virology · doi:10.1016/j.virol.2017.11.021 · Cited by 47
An improved plaque reduction virus neutralization assay for human metapneumovirus
de Graaf, M., Herfst, S., Schrauwen, E. J. A., van den Hoogen, B. G., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2007) · Journal of Virological Methods · doi:10.1016/j.jviromet.2007.03.005 · Cited by 46
JNJ872 inhibits influenza A virus replication without altering cellular antiviral responses
Fu, Y., Gaelings, L., Söderholm, S., Belanov, S., Nandania, J., Nyman, T. A., Matikainen, S., Anders, S., Velagapudi, V., & Kainov, D. E. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.07.008 · Cited by 45
Self-citationAntiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins
Bulanova, D. R., Ianevski, A., Bugai, A., Akimov, Y. A., Kuivanen, S. H., Paavilainen, H., Kakkola, L., Nandania, J., Turunen, L., Öhman, T., et al. (2017) · Viruses · doi:10.3390/v9100271 · Cited by 44
Self-citationThiazolides as Novel Antiviral Agents. 2. Inhibition of Hepatitis C Virus Replication
Stachulski, A. V., Pidathala, C., Row, E. C., Sharma, R., Berry, N. G., Lawrenson, A. S., Moores, S. L., Iqbal, M., Bentley, J., Allman, S. A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201264t · Cited by 44
Cairns, D. M., Boorgu, D. S. S. K., Levin, M. G., & Kaplan, D. L. (2018) · Biology Open · doi:10.1242/bio.031807 · Cited by 43
Simonin, Y., Erkilic, N., Damodar, K., Clé, M., Desmetz, C., Bolloré, K., Taleb, M., Torriano, S., Barthelemy, J., Dubois, G., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.010 · Cited by 43
Carter, M. E., & Shieh, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800511-8.00014-9 · Cited by 43
Expanding the activity spectrum of antiviral agents
Ianevski, A., Andersen, P. I., Merits, A., Bjørås, M., & Kainov, D. E. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.04.006 · Cited by 42
Self-citationInhibition by Cellular Vacuolar ATPase Impairs Human Papillomavirus Uncoating and Infection
Müller, K. H., Spoden, G. A., Scheffer, K. D., Brunnhoefer, R., Brabander, J. K. D., Maier, M. E., Florin, L., & Muller, C. P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02284-13 · Cited by 35
Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation
Huang, L., Yang, M., Yuan, Y., Li, X., & Kuang, E. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.12.002 · Cited by 35
Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs
Schor, S., & Einav, S. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00268 · Cited by 33
Editorial: Drug Repositioning: Current Advances and Future Perspectives
Nishimura, Y., & Hara, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01068 · Cited by 33
Koban, R., Neumann, M., Daugs, A., Bloch, O., Nitsche, A., Langhammer, S., & Ellerbrok, H. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.005 · Cited by 30
Animal models in virus research: their utility and limitations
Louz, D., Bergmans, H. E. N., Loos, B. P., & Hoeben, R. C. (2012) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.711740 · Cited by 29
Iwasawa, C., Tamura, R., Sugiura, Y., Suzuki, S., Kuzumaki, N., Narita, M., Suematsu, M., Nakamura, M., Yoshida, K., Toda, M., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040810 · Cited by 27
The electroretinogram of the iguana and tokay gecko
Meneghini, K. A., & Hamasaki, D. I. (1967) · Vision Research · doi:10.1016/0042-6989(67)90088-0 · Cited by 24
Nucleic acid hybridization in viral diagnosis
Landry, M. L. (1990) · Clinical Biochemistry · doi:10.1016/0009-9120(90)80053-l · Cited by 21
Alves, M. P., Vielle, N. J., Thiel, V., & Pfaender, S. (2018) · Viruses · doi:10.3390/v10110593 · Cited by 16
Cited by
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B., & Wu, J. C. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0413-9 · Cited by 1,409
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
Drożdżal, S., Rosik, J., Lechowicz, K., Machaj, F., Szostak, B., Przybyciński, J., Lorzadeh, S., Kotfis, K., Ghavami, S., & Łos, M. J. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100794 · Cited by 286
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
Tompa, D. R., Immanuel, A., Srikanth, S., & Kadhirvel, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.076 · Cited by 257
Verma, A. K., & Aggarwal, R. (2021) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13812 · Cited by 54
Rabben, H.-L., Andersen, G. T., Ianevski, A., Olsen, M. K., Kainov, D., Grønbech, J. E., Wang, T. C., Chen, D., & Zhao, C.-M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.625991 · Cited by 24
“However, ivermectin has been repositioned as a broad-spectrum antiviral and antimicrobial agent (Andersen et al., 2020).”
BackgroundSelf-citation
Metadata
- Authors
- Andersen, P. I., Ianevski, A., Lysvand, H., Vitkauskiene, A., Oksenych, V., Bjørås, M., Telling, K., Lutsar, I., Dumpis, U., Irie, Y., Tenson, T., Kantele, A., & Kainov, D. E.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 93
- Pages
- 268-276
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W2980655992
- Cited by
- 280
- References
- 113
- FWCI
- 14.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.